The resistin treatment reduced the percentage of cells expressing CD14+CD95+ (36.4 ± 9.2) in the colostrum from diabetic mothers with obesity (Table 2). The gene discussed is RETN; the disease is obesity due to melanocortin 4 receptor deficiency.